Vertex Pharmaceuticals Stock Jumps After The Close: Here's Why - Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex Pharmaceuticals (NASDAQ:VRTX) Price Target Raised to $600.00 at Oppenheimer

Oppenheimer boosted their price target on Vertex Pharmaceuticals from $540.00 to $600.00 and gave the company an "outperform" rating in a research note on Tuesday.

Vertex Pharmaceuticals Stock Jumps After The Close: Here's Why - Vertex Pharmaceuticals (NASDAQ:VRTX)

Vertex shares are rising in extended trading on Monday after the company announces positive interim results for one of its Phase 3 trials.

Capital International Ltd. CA Sells 6,320 Shares of Vertex Pharmaceuticals Incorporated $VRTX

Capital International Ltd. CA trimmed its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.0% during the third quarter, Holdings Channel reports. The institutional investor owned 121,287 shares of the pharmaceutical company’s stock after selling 6,320 shares during the quarter. Vertex Pharmaceuticals makes up about 1.7% of Capital International Ltd. CA’s holdings, making […]